Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 11/20 | 0.61 |
| ▸ | NPC1 | O15118 | 10/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.61 |
| ▸ | HPGD | P15428 | 8/20 | 0.55 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.55 |
| ▸ | RELA | Q04206 | 2/20 | 0.55 |
| ▸ | NOTUM | Q6P988 | 4/20 | 0.53 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL957492 | 0.96 | NPC1 (0.57) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL2612639 | 0.86 | NPC1 (0.49) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL12306748 | 0.85 | NPC1 (0.45) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL24714806 | 0.85 | RAB9A (0.57) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL12306753 | 0.85 | NPC1 (0.47) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL15777560 | 0.85 | NPC1 (0.57) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL12721779 | 0.84 | AKT1 (0.50) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL18195112 | 0.82 | NPC1 (0.66) | RAB9ANPC1HPGDPOLBNOTUM | |
| SCHEMBL16997497 | 0.82 | NPC1 (0.58) | RAB9ANPC1SMN1; SMN2HPGDPOLB | |
| SCHEMBL16997526 | 0.82 | TP53 (0.63) | RAB9ANPC1SMN1; SMN2HPGDATAD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0815598-B1 | BIPOLAR ELECTROLUMINESCENT DEVICE | UNIV OHIO STATE (US) | 2006-02-08 | — | — | EP | claimed |
| EP-0812260-B1 | BIPOLAR ELECTROLUMINESCENT DEVICE | UNIV OHIO STATE (US) | 2003-01-22 | — | — | EP | claimed |
| CN-119431269-A | Method for synthesizing 1,3, 4-oxadiazole compound from 1, 2-dihydrazide compound | 浙江工业大学 | 2025-02-14 | — | — | CN | disclosed |
| US-12024500-B2 | Five-membered ring-substituted pyridazinol compounds and derivatives, preparation methods, herbicidal compositions and applications thereof | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2024-07-02 | — | — | US | disclosed |
| CN-116751174-A | Synthesis method of aryl substituted 1,3, 4-oxadiazole derivative | 铜陵欣诺科新材料有限公司 | 2023-09-15 | — | — | CN | disclosed |
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
| US-11641778-B2 | Compound and organic light emitting device comprising same | LG CHEM, LTD. (KR) | 2023-05-02 | — | — | US | disclosed |
| US-11563187-B2 | Nitrogen-containing compound-containing compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-24 | — | — | US | disclosed |
| US-20220235032-A1 | BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | GENFLEET THERAPEUTICS (SHANGHAI) INC. (CN) | 2022-07-28 | — | — | US | disclosed |
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2021-02-04 | — | — | US | disclosed |
| US-20200317705-A1 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ARIAD PHARMACEUTICALS, INC. | 2020-10-08 | — | — | US | disclosed |
| US-20110230403-A1 | GLYCOSIDE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2011-09-22 | — | — | US | disclosed |
| US-20110230403-A1 | GLYCOSIDE DERIVATIVES AND USES THEREOF | NOVARTIS AG (CH) | 2011-09-22 | — | — | US | disclosed |
| CN-102101852-A | Coumarin derivative, preparation method thereof and application thereof in white light organic electroluminescent device | CHINESE ACAD TECH INST PHYSICS | 2011-06-22 | — | — | CN | disclosed |
| US-20110009366-A1 | BICYCLIC PYRIMIDINONES AND USES THEREOF | AVEXA LIMITED (AU) | 2011-01-13 | — | — | US | disclosed |
| US-20100270915-A1 | Beta-Diketone Ancillary Ligands and Their Metal Complexes Used in Organic Optoelectronic Devices | NATIONAL TSING HUA UNIVERSITY (TW) | 2010-10-28 | — | — | US | disclosed |
| US-20090326016-A1 | FUNGICIDAL N-CYCLOALKYL-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-12-31 | — | — | US | disclosed |
| US-20090326016-A1 | FUNGICIDAL N-CYCLOALKYL-CARBOXAMIDE DERIVATIVES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2009-12-31 | — | — | US | disclosed |
| EP-2025015-A2 | PHOTOACTIVE MATERIALS CONTAINING GROUP IV NANOSTRUCTURES AND OPTOELECTRONIC DEVICES MADE THEREFROM | Innovalight, Inc. (US) | 2009-02-18 | — | — | EP | disclosed |
| WO-2008060704-A2 | PHOTOACTIVE MATERIALS CONTAINING GROUP IV NANOSTRUCTURES AND OPTOELECTRONIC DEVICES MADE THEREFROM | INNOVALIGHT, INC. (US) | 2008-05-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12024500-B2 | Five-membered ring-substituted pyridazinol compounds and derivatives, preparation methods, herbicidal compositions and applications thereof | DDT, CYP3A5, CYP4B1 | RAB9A 1650/4885NPC1 4417/4885SMN1; SMN2 3696/4885 |
| US-11641778-B2 | Compound and organic light emitting device comprising same | CRY1, CYP1A1, CRY2 | RAB9A 2344/4885NPC1 1521/4885SMN1; SMN2 4261/4885 |
| US-20100270915-A1 | Beta-Diketone Ancillary Ligands and Their Metal Complexes Used in Organic Optoelectronic Devices | PBK, DEK, OSTC | RAB9A 4435/4885NPC1 4443/4885SMN1; SMN2 4813/4885 |
| US-20110009366-A1 | BICYCLIC PYRIMIDINONES AND USES THEREOF | TPMT, TYMP, DPYD | RAB9A 2559/4885NPC1 742/4885SMN1; SMN2 1064/4885 |
| US-20110230403-A1 | GLYCOSIDE DERIVATIVES AND USES THEREOF | SLC5A1, SLC5A2, HSD17B14 | RAB9A 2444/4885NPC1 190/4885SMN1; SMN2 2750/4885 |
| US-20200317705-A1 | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | MAP3K6, PIK3CA, MAP3K20 | RAB9A 1513/4885NPC1 3672/4885SMN1; SMN2 4512/4885 |
| US-20220235032-A1 | BISHETEROCYCLIC CARBONYL SUBSTITUTED DIHYDROPYRAZOLE COMPOUND, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF | RIPK1, RIPK4, RIPK3 | RAB9A 1413/4885NPC1 1243/4885SMN1; SMN2 4030/4885 |
| US-20090326016-A1 | FUNGICIDAL N-CYCLOALKYL-CARBOXAMIDE DERIVATIVES | CBR3, CBR1, CYCS | RAB9A 3331/4885NPC1 1902/4885SMN1; SMN2 3909/4885 |
| US-11563187-B2 | Nitrogen-containing compound-containing compound and organic electroluminescence device including the same | L1CAM, C1S, CHRM1 | RAB9A 2601/4885NPC1 1223/4885SMN1; SMN2 1484/4885 |
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | CBR3, CBR1, CYP8B1 | RAB9A 1211/4885NPC1 4435/4885SMN1; SMN2 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.